<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">34948196</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>01</Month>
        <Day>21</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>01</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1422-0067</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>22</Volume>
            <Issue>24</Issue>
            <PubDate>
              <Year>2021</Year>
              <Month>Dec</Month>
              <Day>13</Day>
            </PubDate>
          </JournalIssue>
          <Title>International journal of molecular sciences</Title>
          <ISOAbbreviation>Int J Mol Sci</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The Influence of an Adrenergic Antagonist Guanethidine (GUA) on the Distribution Pattern and Chemical Coding of Dorsal Root Ganglia (DRG) Neurons Supplying the Porcine Urinary Bladder.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">13399</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms222413399</ELocationID>
        <Abstract>
          <AbstractText>Although guanethidine (GUA) was used in the past as a drug to suppress hyperactivity of the sympathetic nerve fibers, there are no available data concerning the possible action of this substance on the sensory component of the peripheral nervous system supplying the urinary bladder. Thus, the present study was aimed at disclosing the influence of intravesically instilled GUA on the distribution, relative frequency, and chemical coding of dorsal root ganglion neurons associated with the porcine urinary bladder. The investigated sensory neurons were visualized with a retrograde tracing method using Fast Blue (FB), while their chemical profile was disclosed with single-labeling immunohistochemistry using antibodies against substance P (SP), calcitonin gene-related peptide (CGRP), pituitary adenylate cyclase activating polypeptide (PACAP), galanin (GAL), neuronal nitric oxide synthase (nNOS), somatostatin (SOM), and calbindin (CB). After GUA treatment, a slight decrease in the number of FB<sup>+</sup> neurons containing SP was observed when compared with untreated animals (34.6 ± 6.5% vs. 45.6 ± 1.3%), while the number of retrogradely traced cells immunolabeled for GAL, nNOS, and CB distinctly increased (12.3 ± 1.0% vs. 7.4 ± 0.6%, 11.9 ± 0.6% vs. 5.4 ± 0.5% and 8.6 ± 0.5% vs. 2.7 ± 0.4%, respectively). However, administration of GUA did not change the number of FB<sup>+</sup> neurons containing CGRP, PACAP, or SOM. The present study provides evidence that GUA significantly modifies the sensory innervation of the porcine urinary bladder wall and thus may be considered a potential tool for studying the plasticity of this subdivision of the bladder innervation.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Janikiewicz</LastName>
            <ForeName>Paweł</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Human Physiology and Pathophysiology, School of Medicine, Collegium Medicum, University of Warmia and Mazury in Olsztyn, Warszawska 30, 10-082 Olsztyn, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wasilewska</LastName>
            <ForeName>Barbara</ForeName>
            <Initials>B</Initials>
            <Identifier Source="ORCID">0000-0001-8802-7758</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Human Physiology and Pathophysiology, School of Medicine, Collegium Medicum, University of Warmia and Mazury in Olsztyn, Warszawska 30, 10-082 Olsztyn, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mazur</LastName>
            <ForeName>Urszula</ForeName>
            <Initials>U</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Human Physiology and Pathophysiology, School of Medicine, Collegium Medicum, University of Warmia and Mazury in Olsztyn, Warszawska 30, 10-082 Olsztyn, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Franke-Radowiecka</LastName>
            <ForeName>Amelia</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Animal Anatomy, Faculty of Veterinary Medicine, University of Warmia and Mazury in Olsztyn, Oczapowskiego 13, 10-719 Olsztyn, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Majewski</LastName>
            <ForeName>Mariusz</ForeName>
            <Initials>M</Initials>
            <Identifier Source="ORCID">0000-0001-5818-7689</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Human Physiology and Pathophysiology, School of Medicine, Collegium Medicum, University of Warmia and Mazury in Olsztyn, Warszawska 30, 10-082 Olsztyn, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bossowska</LastName>
            <ForeName>Agnieszka</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">0000-0002-5446-0171</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Human Physiology and Pathophysiology, School of Medicine, Collegium Medicum, University of Warmia and Mazury in Olsztyn, Warszawska 30, 10-082 Olsztyn, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>13</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Int J Mol Sci</MedlineTA>
        <NlmUniqueID>101092791</NlmUniqueID>
        <ISSNLinking>1422-0067</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D018674">Adrenergic Antagonists</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D064026">Calbindins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D009498">Neurotoxins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D051219">Pituitary Adenylate Cyclase-Activating Polypeptide</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>33507-63-0</RegistryNumber>
          <NameOfSubstance UI="D013373">Substance P</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>51110-01-1</RegistryNumber>
          <NameOfSubstance UI="D013004">Somatostatin</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>88813-36-9</RegistryNumber>
          <NameOfSubstance UI="D019004">Galanin</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 1.14.13.39</RegistryNumber>
          <NameOfSubstance UI="D019001">Nitric Oxide Synthase</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>JHB2QIZ69Z</RegistryNumber>
          <NameOfSubstance UI="D015740">Calcitonin Gene-Related Peptide</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>ZTI6C33Q2Q</RegistryNumber>
          <NameOfSubstance UI="D006145">Guanethidine</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D018674" MajorTopicYN="N">Adrenergic Antagonists</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D059331" MajorTopicYN="N">Adrenergic Neurons</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D064026" MajorTopicYN="N">Calbindins</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015740" MajorTopicYN="N">Calcitonin Gene-Related Peptide</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019004" MajorTopicYN="N">Galanin</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005727" MajorTopicYN="N">Ganglia, Spinal</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006145" MajorTopicYN="N">Guanethidine</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009498" MajorTopicYN="N">Neurotoxins</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019001" MajorTopicYN="N">Nitric Oxide Synthase</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051219" MajorTopicYN="N">Pituitary Adenylate Cyclase-Activating Polypeptide</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011984" MajorTopicYN="N">Sensory Receptor Cells</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013004" MajorTopicYN="N">Somatostatin</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013373" MajorTopicYN="N">Substance P</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013552" MajorTopicYN="N">Swine</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001743" MajorTopicYN="N">Urinary Bladder</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
          <QualifierName UI="Q000294" MajorTopicYN="Y">innervation</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">dorsal root ganglia neurons</Keyword>
        <Keyword MajorTopicYN="N">guanethidine</Keyword>
        <Keyword MajorTopicYN="N">immunohistochemistry</Keyword>
        <Keyword MajorTopicYN="N">neuropeptides</Keyword>
        <Keyword MajorTopicYN="N">pig</Keyword>
        <Keyword MajorTopicYN="N">sensory innervation</Keyword>
        <Keyword MajorTopicYN="N">urinary bladder</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>10</Month>
          <Day>30</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>2</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>24</Day>
          <Hour>1</Hour>
          <Minute>17</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>25</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34948196</ArticleId>
        <ArticleId IdType="pmc">PMC8708101</ArticleId>
        <ArticleId IdType="doi">10.3390/ijms222413399</ArticleId>
        <ArticleId IdType="pii">ijms222413399</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>De Groat W.C., Steers W.D.  Central Regulation of Autonomic Functions. Oxford University Press; Oxford, UK: 1990. Autonomic Regulation of the Urinary Bladder and Sex Organs; pp. 310–333.</Citation>
        </Reference>
        <Reference>
          <Citation>Habler H.J., Janig W., Koltzenburg M. Activation of unmyelinated afferent fibres by mechanical stimuli and inflammation of the urinary bladder in the cat. J. Physiol. 1990;425:545–562. doi: 10.1113/jphysiol.1990.sp018117.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1113/jphysiol.1990.sp018117</ArticleId>
            <ArticleId IdType="pmc">PMC1189862</ArticleId>
            <ArticleId IdType="pubmed">2213588</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Callsen-Cencic P., Mense S. Expression of neuropeptides and nitric oxide synthase in neurons innervating the inflamed rat urinary bladder. J. Auton. Nerv. Syst. 1997;65:33–44. doi: 10.1016/S0165-1838(97)00032-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0165-1838(97)00032-5</ArticleId>
            <ArticleId IdType="pubmed">9258870</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhou Y., Ling E.A. Increased NADPH-diaphorase reactivity in bladder afferent pathways following urethral obstruction in guinea pigs. J. Peripher. Nerv. Syst. 1997;2:333–342.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10975742</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yoshimura N., de Groat W.C. Plasticity of Na+ channels in afferent neurons innervating rat urinary bladder following spinal cord injury. J Physiol. 1997;503:269–276. doi: 10.1111/j.1469-7793.1997.269bh.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1469-7793.1997.269bh.x</ArticleId>
            <ArticleId IdType="pmc">PMC1159861</ArticleId>
            <ArticleId IdType="pubmed">9306271</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bossowska A., Crayton R., Radziszewski P., Kmieć Z., Majewski M. Distribution and neurochemical characterization of sensory dorsal root ganglia neurons supplying porcine urinary bladder. J. Physiol. Pharmacol. 2009;60:77–81.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20083855</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Abbs E.T., Dodd M.G. The Relation between the adrenergic neurone-blocking and noradrenaline-depleting actions of some guanidine derivatives. Br. J. Pharmac. 1974;51:237–247. doi: 10.1111/j.1476-5381.1974.tb09653.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1476-5381.1974.tb09653.x</ArticleId>
            <ArticleId IdType="pmc">PMC1776754</ArticleId>
            <ArticleId IdType="pubmed">4451743</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maxwell R.A., Mull R.P., Plummer A.J. 2-Octahydro-1-azocinyl)-ethyl]-guanidine sulphate (CIBA 5864-SU), a new synthetic antihypertensive agents. Experientia. 1959;15:267. doi: 10.1007/BF02158076.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/BF02158076</ArticleId>
            <ArticleId IdType="pubmed">13848628</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brodie B.B., Chang C.C., Costa E. On the mechanism of action of guanethidine and bretylium. Brit. J. Pharmacol. 1965;25:171–178. doi: 10.1111/j.1476-5381.1965.tb01769.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1476-5381.1965.tb01769.x</ArticleId>
            <ArticleId IdType="pmc">PMC1510669</ArticleId>
            <ArticleId IdType="pubmed">19108194</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boullin D.J. A calcium requirement for release of 3H-guanethidine by sympathetic nerve stimulation. J. Pharm. Pharmacol. 1966;18:709–712. doi: 10.1111/j.2042-7158.1966.tb07791.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.2042-7158.1966.tb07791.x</ArticleId>
            <ArticleId IdType="pubmed">4382046</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oates J.A., Mitchell J.R., Feagin O.T. Distribution of guanidium antihypertensive—Mechanism of their selective action. Ann. N. Y. Acad. Sci. 1971;179:302–308. doi: 10.1111/j.1749-6632.1971.tb46909.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1749-6632.1971.tb46909.x</ArticleId>
            <ArticleId IdType="pubmed">5285379</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maxwell R.A. Guanethidine after twenty years: A pharmacologist’s perspective. Br. J. Clin. Pharmacol. 1982;13:35–44. doi: 10.1111/j.1365-2125.1982.tb01334.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1365-2125.1982.tb01334.x</ArticleId>
            <ArticleId IdType="pmc">PMC1401772</ArticleId>
            <ArticleId IdType="pubmed">6121572</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Supowit S.C., Ethridge R.T., Zhao H., Katki K.A., Dipette D.J. Calcitonin gene-related peptide and substance P contribute to reduced blood pressure in sympathectomized rats. Am. J. Physiol. Heart Circ. Physiol. 2005;289:H1169–H1175. doi: 10.1152/ajpheart.00973.2004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpheart.00973.2004</ArticleId>
            <ArticleId IdType="pubmed">15879482</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brauer M.M., Lincoln J., Milner P., Sarner S., Blundell D., Passaro M., Corbacho A., Burnstock G. Plasticity of autonomic nerves: Differential effects of long-term guanethidine sympathectomy on the sensory innervation of the rat uterus during maturation. Int. J. Dev. Neurosci. 1994;12:579–586. doi: 10.1016/0736-5748(94)90065-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0736-5748(94)90065-5</ArticleId>
            <ArticleId IdType="pubmed">7534446</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chalar C., Richeri A., Viettro L., Chávez-Genaro R., Bianchimano P., Marmol N.M., Crutcher K., Burnstock G., Cowen T., Brauer M.M. Plasticity in developing rat uterine sensory nerves: The role of NGF and TrkA. Cell Tissue Res. 2003;314:191–205. doi: 10.1007/s00441-003-0799-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00441-003-0799-9</ArticleId>
            <ArticleId IdType="pubmed">13680358</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bustamante S., Orensanz L.M., Recio P., Carballido J., García-Sacristán A., Prieto D., Hernández M. Functional evidence of nitrergic neurotransmission in the human urinary bladder neck. Neurosci. Lett. 2010;477:91–94. doi: 10.1016/j.neulet.2010.04.040.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neulet.2010.04.040</ArticleId>
            <ArticleId IdType="pubmed">20417249</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Creed K.E., Ishikawa S., Ito Y. Electrical and mechanical activity recorded from rabbit urinary bladder in response to nerve stimulation. J. Physiol. 1983;338:149–164. doi: 10.1113/jphysiol.1983.sp014666.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1113/jphysiol.1983.sp014666</ArticleId>
            <ArticleId IdType="pmc">PMC1197187</ArticleId>
            <ArticleId IdType="pubmed">6308243</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Koley B., Koley J., Saha J.K. The effects of nicotine on spontaneous contractions of cat urinary bladder in situ. Br. J. Pharmacol. 1984;83:347–355. doi: 10.1111/j.1476-5381.1984.tb16494.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1476-5381.1984.tb16494.x</ArticleId>
            <ArticleId IdType="pmc">PMC1987122</ArticleId>
            <ArticleId IdType="pubmed">6487900</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shinkai M., Takayanagi I., Kato T. Contrasting effects of tachykinins and guanethidine on the acetylcholine output stimulated by nicotine from guinea-pig bladder [corrected] Br. J. Pharmacol. 1991;103:1191–1195. doi: 10.1111/j.1476-5381.1991.tb12322.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1476-5381.1991.tb12322.x</ArticleId>
            <ArticleId IdType="pmc">PMC1908085</ArticleId>
            <ArticleId IdType="pubmed">1715227</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thornbury K.D., Donaghy K.M., Peake J. Characteristics of the NANC post-stimulus (‘rebound’) contraction of the urinary bladder neck muscle in sheep. Br. J. Pharmacol. 1995;116:2451–2456. doi: 10.1111/j.1476-5381.1995.tb15095.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1476-5381.1995.tb15095.x</ArticleId>
            <ArticleId IdType="pmc">PMC1909037</ArticleId>
            <ArticleId IdType="pubmed">8581284</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Min C.H., Wang Y., Bae J., Han J.H., Sohn U.D. The Inhibitory Mechanism of Gentamicin on Electrical Field Stimulation Response in Rat Bladder Smooth Muscle. Korean J. Physiol. Pharmacol. 2015;19:473–478. doi: 10.4196/kjpp.2015.19.5.473.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4196/kjpp.2015.19.5.473</ArticleId>
            <ArticleId IdType="pmc">PMC4553408</ArticleId>
            <ArticleId IdType="pubmed">26330761</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chang H.H., Chang S.-J., Hsieh C.-H., Hsu C.-K., Yang S.S.-D. Capsaicin-Sensitive Sensory Nerves Indirectly Modulate Motor Function of the Urinary Bladder. Int. Neurourol. J. 2018;22:83–89. doi: 10.5213/inj.1836078.039.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5213/inj.1836078.039</ArticleId>
            <ArticleId IdType="pmc">PMC6059914</ArticleId>
            <ArticleId IdType="pubmed">29991229</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hernández M., Knight G.E., Wildman S.S.P., Burnstock G. Role of ATP and related purines in inhibitory neurotransmission to the pig urinary bladder neck. Br. J. Pharmacol. 2009;157:1463–1473. doi: 10.1111/j.1476-5381.2009.00314.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1476-5381.2009.00314.x</ArticleId>
            <ArticleId IdType="pmc">PMC2765313</ArticleId>
            <ArticleId IdType="pubmed">19563528</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Martínez-Sáenz A., Recio P., Orensanz L.M., Fernandes V.S., Pilar Martínez M., Bustamante S., Carballido J., García-Sacristán A., Prieto D., Hernández M. Role of Calcitonin Gene-Related Peptide in Inhibitory Neurotransmission to the Pig Bladder Neck. J. Urol. 2011;186:728–735. doi: 10.1016/j.juro.2011.03.142.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.juro.2011.03.142</ArticleId>
            <ArticleId IdType="pubmed">21683385</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moro C., Chess-Williams R. Non-adrenergic, non-cholinergic, non-purinergic contractions of the urothelium/lamina propria of the pig bladder. Auton. Autacoid Pharmacol. 2012;32:53–59. doi: 10.1111/aap.12000.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/aap.12000</ArticleId>
            <ArticleId IdType="pubmed">22994938</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dalmose A.L., Hvistendahl J.J., Olsen L.H., Eskild-Jensen A., Djurhuus J.C., Swindle M.M. Surgically induced urologic models in swine. J. Investig. Surg. 2000;13:133–145.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10933109</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Swindle M.M., Makin A., Herron A.J., Clubb F.J., Jr., Frazier K.S. Swine as models in biomedical research and toxicology testing. Vet. Pathol. 2012;49:344–356. doi: 10.1177/0300985811402846.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/0300985811402846</ArticleId>
            <ArticleId IdType="pubmed">21441112</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bossowska A., Lepiarczyk E., Mazur U., Janikiewicz P., Markiewicz W. Botulinum toxin type A induces changes in the chemical coding of substance P-immunoreactive dorsal root ganglia sensory neurons supplying the porcine urinary bladder. Toxins. 2015;7:4797–4816. doi: 10.3390/toxins7114797.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/toxins7114797</ArticleId>
            <ArticleId IdType="pmc">PMC4663534</ArticleId>
            <ArticleId IdType="pubmed">26580655</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vaughan C.W., Satchell P.M. Urine storage mechanisms. Prog. Neurobiol. 1995;46:215–237. doi: 10.1016/0301-0082(95)80012-W.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0301-0082(95)80012-W</ArticleId>
            <ArticleId IdType="pubmed">7568914</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maggi C.A. Tachykinins as peripheral modulators of primary afferent nerves and visceral sensitivity. Pharmacol. Res. 1997;36:153–169. doi: 10.1006/phrs.1997.0219.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1006/phrs.1997.0219</ArticleId>
            <ArticleId IdType="pubmed">9344645</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Keast J.R., De Groat W.C. Segmental distribution and peptide content of primary afferent neurons innervating the urogenital organs and colon of male rats. J. Comp. Neurol. 1992;319:615–623. doi: 10.1002/cne.903190411.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/cne.903190411</ArticleId>
            <ArticleId IdType="pubmed">1619047</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vizzard M.A. Alterations in neuropeptide expression in lumbosacral bladder pathways following chronic cystitis. J Chem. Neuroanat. 2001;21:125–138. doi: 10.1016/S0891-0618(00)00115-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0891-0618(00)00115-0</ArticleId>
            <ArticleId IdType="pubmed">11312054</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mersdorf A., Schmidt R.A., Kaula N., Tanagho E.A. Intrathecal administration of substance P in the rat: The effect on bladder and urethral sphincteric activity. Urology. 1992;40:87–96. doi: 10.1016/0090-4295(92)90446-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0090-4295(92)90446-4</ArticleId>
            <ArticleId IdType="pubmed">1377848</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lecci A., Maggi C.A. Spinal cord tachykinins in the micturition reflex. Prog. Brain Res. 1995;104:145–159.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8552766</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shirakawa J., Nakanishi T., Taniyama K., Kamidono S., Tanaka C. Regulation of the substance P-induced contraction via the release of acetylcholine and gamma-aminobutyric acid in the guinea-pig urinary blader. Br. J. Pharmacol. 1989;98:437–444. doi: 10.1111/j.1476-5381.1989.tb12615.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1476-5381.1989.tb12615.x</ArticleId>
            <ArticleId IdType="pmc">PMC1854731</ArticleId>
            <ArticleId IdType="pubmed">2479440</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ahluwalia A., Maggi C.A., Santicioli P., Lecci A., Giuliani S. Characterization of the capsaicin-sensitive component of cyclophosphamide-induced inflammation in the rat urinary bladder. Br. J. Pharmacol. 1994;111:1017–1022. doi: 10.1111/j.1476-5381.1994.tb14845.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1476-5381.1994.tb14845.x</ArticleId>
            <ArticleId IdType="pmc">PMC1910135</ArticleId>
            <ArticleId IdType="pubmed">8032584</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ahluwalia A., Giuliani S., Scotland R., Maggi C.A. Ovalbumin-induced neurogenic inflammation in the bladder of sensitized rats. Br. J. Pharmacol. 1998;124:190–196. doi: 10.1038/sj.bjp.0701793.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.bjp.0701793</ArticleId>
            <ArticleId IdType="pmc">PMC1565355</ArticleId>
            <ArticleId IdType="pubmed">9630359</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lang C.W., Hope P.J. Evidence for localized release of substance P within rat spinal cord evoked by physiological and electrical stimuli. Neuropeptides. 1994;26:413–419. doi: 10.1016/0143-4179(94)90027-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0143-4179(94)90027-2</ArticleId>
            <ArticleId IdType="pubmed">7523981</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Duggan A.W., Riley R.C., Mark M.A., MacMillan S.J., Schaible H.G. Afferent volley patterns and the spinal release of immunoreactive substance P in the dorsal horn of the anaesthetized spinal cat. Neuroscience. 1995;65:849–858. doi: 10.1016/0306-4522(94)00541-C.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0306-4522(94)00541-C</ArticleId>
            <ArticleId IdType="pubmed">7541904</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cammack C., Logan S.D. Excitation of rat sympathetic preganglionic neurons by selective activation of the NK1 receptor. J. Auton. Nerv. Syst. 1996;57:87–92. doi: 10.1016/0165-1838(95)00103-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0165-1838(95)00103-4</ArticleId>
            <ArticleId IdType="pubmed">8867090</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lundberg J.M. Pharmacology of cotransmission in the autonomic nervous system: Integrative aspects on amines, neuropeptides, adenosine triphosphate, amino acids and nitric oxide. Pharmacol. Rev. 1996;48:113–178.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8685245</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chien C.T., Yu H.J., Lin T.B., Lai M.K., Hsu S.M. Substance P via NK1 receptor facilitates hyperactive bladder afferent signaling via action of ROS. Am. J. Physiol. Renal Physiol. 2003;284:F840–F851. doi: 10.1152/ajprenal.00187.2002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajprenal.00187.2002</ArticleId>
            <ArticleId IdType="pubmed">12620925</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Richardson J.D., Vasko M.R. Cellular mechanisms of neurogenic inflammation. J. Pharmacol. Exp. Ther. 2002;302:839–845. doi: 10.1124/jpet.102.032797.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1124/jpet.102.032797</ArticleId>
            <ArticleId IdType="pubmed">12183638</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Candenas L., Lecci A., Pinto F.M., Patak E., Maggi C.A., Pennefather J.N. Tachykinins and tachykinin receptors: Effects in the genitourinary tract. Life Sci. 2005;76:835–862. doi: 10.1016/j.lfs.2004.10.004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.lfs.2004.10.004</ArticleId>
            <ArticleId IdType="pubmed">15589963</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Giuliani S., Santicioli P., Lippe I.T., Lecci A., Maggi C.A. Effect of bradykinin and tachykinin receptor antagonist on xylene-induced cystitis in rats. J. Urol. 1993;150:1014–1017. doi: 10.1016/S0022-5347(17)35677-X.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0022-5347(17)35677-X</ArticleId>
            <ArticleId IdType="pubmed">7688430</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Terenghi G., Zhang S.Q., Unger W.G., Polack J.M. Morphological changes of CGRP-immunoreactive and sympathetic nerves in peripheral tissues following chronic denervation. Histochemistry. 1986;86:89–95. doi: 10.1007/BF00492350.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/BF00492350</ArticleId>
            <ArticleId IdType="pubmed">2878909</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fiskerstrand C., Quinn J.P. The molecular biology of preprotachykinin-A gene expression. Neuropeptides. 1996;30:602–610. doi: 10.1016/S0143-4179(96)90044-X.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0143-4179(96)90044-X</ArticleId>
            <ArticleId IdType="pubmed">9004259</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Korsching S., Thoener H. Nerve growth factor supply for sensory neurons: Site of origin and competition with the sympathetic nervous system. Neurosci. Lett. 1985;54:201–205. doi: 10.1016/S0304-3940(85)80079-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0304-3940(85)80079-3</ArticleId>
            <ArticleId IdType="pubmed">3873029</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yodlowski M.L., Fredieu J.R., Landis S.C. Neonatal 6-hydroxydopamine treatment eliminates cholinergic sympathetic innervation and induces sensory sprouting in rat sweat glands. J. Neurosci. 1984;4:1535–1548. doi: 10.1523/JNEUROSCI.04-06-01535.1984.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.04-06-01535.1984</ArticleId>
            <ArticleId IdType="pmc">PMC6564974</ArticleId>
            <ArticleId IdType="pubmed">6427423</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Trevisani M., Campi B., Gatti R., Andre E., Materazzi S., Nicoletti P., Gazzieri D., Geppetti P. The Influence of Alpha1-Adrenoreceptors on Neuropeptide Release from Primary Sensory Neurons of the Lower Urinary Tract. Eur. Urol. 2007;52:901–908. doi: 10.1016/j.eururo.2007.01.016.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.eururo.2007.01.016</ArticleId>
            <ArticleId IdType="pubmed">17240043</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu H.X., Hokfelt T. The participation of galanin in pain processing at the spinal level. Trends Pharmacol. Sci. 2002;23:468–474. doi: 10.1016/S0165-6147(02)02074-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0165-6147(02)02074-6</ArticleId>
            <ArticleId IdType="pubmed">12368071</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Colvin L.A., Mark M.A., Duggan A.W. The effect of a peripheral mononeuropathy on immunoreactive (ir)-galanin release in the spinal cord of the rat. Brain Res. 1997;766:259–261. doi: 10.1016/S0006-8993(97)00700-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0006-8993(97)00700-2</ArticleId>
            <ArticleId IdType="pubmed">9359612</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu H., Hokfelt T. Effect of intrathecal galanin and its putative antagonist M35 on pain behavior in a neuropathic pain model. Brain Res. 2000;886:67–72. doi: 10.1016/S0006-8993(00)02791-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0006-8993(00)02791-8</ArticleId>
            <ArticleId IdType="pubmed">11119688</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wiesenfeld-Hallin Z., Bartfai T., Hökfelt T. Galanin in sensory neurons in the spinal cord. Front Neuroendocrinol. 1992;13:319–343.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1281124</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu X.J., Wiesenfeld-Hallin Z., Villar M.J., Hökfelt T. Intrathecal galanin antagonizes the facilitatory effect of substance P on the nociceptive flexor reflex in the rat. Acta Physiol. Scand. 1989;137:463–464. doi: 10.1111/j.1748-1716.1989.tb08780.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1748-1716.1989.tb08780.x</ArticleId>
            <ArticleId IdType="pubmed">2480699</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lecci A., Giuliani S., Garret C., Maggi C.A. Evidence for a role of tachykinins as sensory transmitters in the activation of micturition reflex. Neuroscience. 1993;54:827–837. doi: 10.1016/0306-4522(93)90252-B.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0306-4522(93)90252-B</ArticleId>
            <ArticleId IdType="pubmed">8101362</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yau W.M., Dorsett J.A., Youther M.L. Evidence for galanin as an inhibitory neuropeptide on myenteric cholinergic neurons in the guinea pig small intestine. Neurosci. Lett. 1986;72:305–308. doi: 10.1016/0304-3940(86)90531-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0304-3940(86)90531-8</ArticleId>
            <ArticleId IdType="pubmed">2434887</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maggi C.A., Santicioli P., Patacchini R., Turini D., Barbanti G., Beneforti P., Giuliani S., Meli A. Galanin: A potent modulator of excitatory neurotransmission in the human urinary bladder. Eur. J. Pharmacol. 1987;143:135–137. doi: 10.1016/0014-2999(87)90744-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0014-2999(87)90744-8</ArticleId>
            <ArticleId IdType="pubmed">2446889</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Honda M., Yoshimura N., Inoue S., Hikita K., Muraoka K., Saito M., Chancellor M.B., Takenaka A. Inhibitory role of the spinal galanin system in the control of micturition. Urology. 2013;82:1188.e9–1188.e14. doi: 10.1016/j.urology.2013.06.056.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.urology.2013.06.056</ArticleId>
            <ArticleId IdType="pmc">PMC3920735</ArticleId>
            <ArticleId IdType="pubmed">24035037</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zvarova K., Murray E., Vizzard M.A. Changes in galanin immunoreactivity in rat lumbosacral spinal cord and dorsal root ganglia after spinal cord injury. J. Comp. Neurol. 2004;475:590–603. doi: 10.1002/cne.20195.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/cne.20195</ArticleId>
            <ArticleId IdType="pubmed">15236239</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jimenez-Andrade J.M., Zhou S., Du J., Yamani A., Grady J.J., Castaneda-Hernandez G., Carlton S.M. Pronociceptive role of peripheral galanin in inflammatory pain. Pain. 2004;110:10–21. doi: 10.1016/j.pain.2004.02.032.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.pain.2004.02.032</ArticleId>
            <ArticleId IdType="pubmed">15275747</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Elliott-Hunt C.R., Pope R.J., Vanderplank P., Wynick D. Activation of the galanin receptor 2 (GalR2) protects the hippocampus from neuronal damage. J. Neurochem. 2007;100:780–789. doi: 10.1111/j.1471-4159.2006.04239.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1471-4159.2006.04239.x</ArticleId>
            <ArticleId IdType="pmc">PMC2705497</ArticleId>
            <ArticleId IdType="pubmed">17263796</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zvarova K., Vizzard M.A. Changes in galanin immunoreactivity in rat micturition reflex pathways after cyclophosphamide-induced cystitis. Cell Tissue Res. 2006;324:213–224. doi: 10.1007/s00441-005-0114-z.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00441-005-0114-z</ArticleId>
            <ArticleId IdType="pubmed">16491427</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Meller S.T., Gebhart G.F. Nitric oxide (NO) and nociceptive processing in the spinal cord. Pain. 1993;52:127–136. doi: 10.1016/0304-3959(93)90124-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0304-3959(93)90124-8</ArticleId>
            <ArticleId IdType="pubmed">8455960</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Birder L.A., Kanai A.J., de Groat W.C., Kiss S., Nealen M.L., Burke N.E., Dineley K.E., Watkins S., Reynolds I.J., Caterina M.J. Vanilloid receptor expression suggests a sensory role for urinary bladder epithelial cells. Proc. Natl. Acad. Sci. USA. 2001;98:13396–13401. doi: 10.1073/pnas.231243698.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.231243698</ArticleId>
            <ArticleId IdType="pmc">PMC60882</ArticleId>
            <ArticleId IdType="pubmed">11606761</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rice A.S. Topical spinal administration of a nitric oxide synthase inhibitor prevents the hyperreflexia associated with a rat model of persistent visceral pain. Neurosci. Lett. 1995;187:111–114. doi: 10.1016/0304-3940(95)11356-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0304-3940(95)11356-8</ArticleId>
            <ArticleId IdType="pubmed">7540269</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kakizaki H., De Groat W.C. Role of spinal nitric oxide in the facilitation of the micturition reflex by bladder irritation. J. Urol. 1996;155:355–360. doi: 10.1016/S0022-5347(01)66660-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0022-5347(01)66660-6</ArticleId>
            <ArticleId IdType="pubmed">7490886</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aley K.O., Mc Carter G., Levine J.D. Nitric oxide signaling in pain and nociceptor sensitization in the rat. J. Neurosci. 1998;18:7008–7014. doi: 10.1523/JNEUROSCI.18-17-07008.1998.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.18-17-07008.1998</ArticleId>
            <ArticleId IdType="pmc">PMC6792985</ArticleId>
            <ArticleId IdType="pubmed">9712669</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Renganathan M., Cummins T.R., Hormuzdiar W.N., Black J.A., Waxman S.G. Nitric oxide is an autocrine regulator of Na(+) currents in axotomized C-type DRG neurons. J. Neurophysiol. 2000;83:2431–2442. doi: 10.1152/jn.2000.83.4.2431.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/jn.2000.83.4.2431</ArticleId>
            <ArticleId IdType="pubmed">10758144</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ho M.H., Bhatia N.N., Khorram O. Physiologic role of nitric oxide and nitric oxide synthase in female lower urinary tract. Curr. Opin. Obstet. Gynecol. 2004;16:423–429. doi: 10.1097/00001703-200410000-00012.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/00001703-200410000-00012</ArticleId>
            <ArticleId IdType="pubmed">15353953</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Persson K., Andersson K.E. Nitric oxide and relaxation of pig lower urinary tract. Br. J. Pharmacol. 1992;106:416–422. doi: 10.1111/j.1476-5381.1992.tb14349.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1476-5381.1992.tb14349.x</ArticleId>
            <ArticleId IdType="pmc">PMC1907485</ArticleId>
            <ArticleId IdType="pubmed">1393268</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Persson K., Alm P., Johansson K., Larsson B., Andersson K.E. Nitric oxide synthase in pig lower urinary tract: Immuno-histochemistry, NADPH diaphorase histochemistry and functional effects. Br. J. Pharmacol. 1993;110:521–530. doi: 10.1111/j.1476-5381.1993.tb13842.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1476-5381.1993.tb13842.x</ArticleId>
            <ArticleId IdType="pmc">PMC2175945</ArticleId>
            <ArticleId IdType="pubmed">7694752</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schwaller B., Meyer M., Schiffmann S. ‘New’ functions for ‘old’ proteins: The role of the calcium binding proteins calbindin D-28k, calretinin and parvalbumin, in cerebellar physiology. Studies with knockout mice. Cerebellum. 2002;1:241–258. doi: 10.1080/147342202320883551.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/147342202320883551</ArticleId>
            <ArticleId IdType="pubmed">12879963</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Choi W.S., Lee E., Lim J., Oh Y.J. Calbindin-D28K prevents drug-induced dopaminergic neuronal death by inhibiting caspase and calpain activity. Biochem. Biophys. Res. Commun. 2008;371:127–131. doi: 10.1016/j.bbrc.2008.04.020.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbrc.2008.04.020</ArticleId>
            <ArticleId IdType="pubmed">18413141</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Choi W.S., Oh Y.J. Calbindin-D28K prevents staurosporin induced Bax cleavage and membrane permeabilization. Exp. Neurobiol. 2014;23:173–177. doi: 10.5607/en.2014.23.2.173.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5607/en.2014.23.2.173</ArticleId>
            <ArticleId IdType="pmc">PMC4065832</ArticleId>
            <ArticleId IdType="pubmed">24963283</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baimbridge K.G., Celio M.R., Rogers J.H. Calcium-binding proteins in the nervous system. Trends Neurosci. 1992;15:303–308. doi: 10.1016/0166-2236(92)90081-I.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0166-2236(92)90081-I</ArticleId>
            <ArticleId IdType="pubmed">1384200</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Honda C.N. Differential distribution of calbindin-D28k and parvalbumin in somatic and visceral sensory neurons. Neuroscience. 1995;68:883–892. doi: 10.1016/0306-4522(95)00180-Q.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0306-4522(95)00180-Q</ArticleId>
            <ArticleId IdType="pubmed">8577381</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li Y.N., Sakamoto H., Kawate T., Cheng C.X., Li Y.C., Shimada O., Atsumi S. An immunocytochemical study of calbindin-D28K in laminae I and II of the dorsal horn and spinal ganglia in the chicken with special reference to the relation to substance P-containing primary afferent neurons. Arch. Histol. Cytol. 2005;68:57–70. doi: 10.1679/aohc.68.57.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1679/aohc.68.57</ArticleId>
            <ArticleId IdType="pubmed">15827379</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Biella G., Panara C., Pecile A., Sotgiu M.L. Facilitatory role of calcitonin gene-related peptide (CGRP) on excitation induced by substance P (SP) and noxious stimuli in rat spinal dorsal horn neurons. An iontophoretic study in vivo. Brain Res. 1991;559:352–356. doi: 10.1016/0006-8993(91)90024-P.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0006-8993(91)90024-P</ArticleId>
            <ArticleId IdType="pubmed">1724408</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Le Greves P., Nyberg F., Terenius L., Hokfelt T. Calcitonin gene-related peptide is a potent inhibitor of substance P degradation. Eur. J. Pharmacol. 1985;115:309–311. doi: 10.1016/0014-2999(85)90706-X.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0014-2999(85)90706-X</ArticleId>
            <ArticleId IdType="pubmed">2415371</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oku R., Satoh M., Fujii N., Otaka A., Yajima H., Takagi H. Calcitonin gene-related peptide promotes mechanical nociception by potentiating release of substance P from the spinal dorsal horn in rats. Brain. Res. 1987;403:350–354. doi: 10.1016/0006-8993(87)90074-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0006-8993(87)90074-6</ArticleId>
            <ArticleId IdType="pubmed">2435372</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maggi C.A.  The dual function of capsaicin-sensitive sensory nerves in the bladder and urethra. In: Maggi C.A., editor. The Autonomic Nervous System. Nervous Control of the Urogenital System. Volume 2 Harwood Academic Publishers; London, UK: 1992. </Citation>
        </Reference>
        <Reference>
          <Citation>Andersson K.E. Pharmacology of lower urinary tract smooth muscles and penile erectile tissues. Pharmacol. Rev. 1993;45:253–308.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8248281</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aberdeen J., Corr L., Milner P., Lincoln J., Burnstock G. Marked increase in calcitonin gene-related peptide containing nerves in the developing rat following long-term sympathectomy with guanethidine. Neuroscience. 1990;35:175–184. doi: 10.1016/0306-4522(90)90132-N.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0306-4522(90)90132-N</ArticleId>
            <ArticleId IdType="pubmed">2113638</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mione M.C., Cavanagh J.F.R., Kirkpatrick K.A., Burnstock G. Plasticity in expression of calcitonin gene-related peptide and substance P immunoreactivity in ganglia and fibres following guanethidine and/or capsaicin denervation. Cell Tissue Res. 1992;268:491–504. doi: 10.1007/BF00319156.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/BF00319156</ArticleId>
            <ArticleId IdType="pubmed">1378354</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ishizuka O., Alm P., Larsson B., Mattiasson A., Andersson K.E. Facilitatory effect of pituitary adenylate cyclase activating polypeptide on micturition in normal, conscious rats. Neuroscience. 1995;66:1009–1014. doi: 10.1016/0306-4522(95)00038-K.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0306-4522(95)00038-K</ArticleId>
            <ArticleId IdType="pubmed">7651605</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Girard B.M., Wolf-Johnston A., Braas K.M., Birder L.A., May V., Vizzard M.A. PACAP-mediated ATP release from rat urothelium and regulation of PACAP/VIP and receptor mRNA in micturition pathways after cyclophosphamide (CYP)-induced cystitis. J. Mol. Neurosci. 2008;36:310–320. doi: 10.1007/s12031-008-9104-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12031-008-9104-4</ArticleId>
            <ArticleId IdType="pmc">PMC2737258</ArticleId>
            <ArticleId IdType="pubmed">18563302</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Braas K.M., May V., Zvara P., Nausch B., Kliment J., Dunleavy J.D., Nelson M.T., Vizzard M.A. Role for pituitary adenylate cyclase activating polypeptide in cystitis-induced plasticity of micturition reflexes. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2006;290:R951–R962. doi: 10.1152/ajpregu.00734.2005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpregu.00734.2005</ArticleId>
            <ArticleId IdType="pmc">PMC1402357</ArticleId>
            <ArticleId IdType="pubmed">16322346</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vizzard M.A. Up-regulation of pituitary adenylate cyclase-activating polypeptide in urinary bladder pathways after chronic cystitis. J. Comp. Neurol. 2000;420:335–348. doi: 10.1002/(SICI)1096-9861(20000508)420:3&lt;335::AID-CNE5&gt;3.0.CO;2-#.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/(SICI)1096-9861(20000508)420:3&lt;335::AID-CNE5&gt;3.0.CO;2-#</ArticleId>
            <ArticleId IdType="pubmed">10754506</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zvarova K., Dunleavy J.D., Vizzard M.A. Changes in pituitary adenylate cyclase activating polypeptide expression in urinary bladder pathways after spinal cord injury. Exp. Neurol. 2005;192:46–59. doi: 10.1016/j.expneurol.2004.10.017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.expneurol.2004.10.017</ArticleId>
            <ArticleId IdType="pubmed">15698618</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ohsawa M., Brailoiu G.C., Shiraki M., Dun N.J., Paul K., Tseng L.F. Modulation of nociceptive transmission by pituitary adenylate cyclase activating polypeptide in the spinal cord of the mouse. Pain. 2002;100:27–34. doi: 10.1016/S0304-3959(02)00207-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0304-3959(02)00207-5</ArticleId>
            <ArticleId IdType="pubmed">12435456</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim W.K., Kan Y., Ganea D., Hart R.P., Gozes I., Jonakait G.M. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit tumor necrosis factor-alpha production in injured spinal cord and in activated microglia via a cAMP-dependent pathway. J. Neurosci. 2000;20:3622–3630. doi: 10.1523/JNEUROSCI.20-10-03622.2000.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.20-10-03622.2000</ArticleId>
            <ArticleId IdType="pmc">PMC6772690</ArticleId>
            <ArticleId IdType="pubmed">10804204</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hernández M., Barahona M.V., Recio P., Benedito S., Martinez A.C., Rivera L., García-Sacristán A., Prieto D., Orensanz L.M. Neuronal and smooth muscle receptors involved in the PACAP- and VIP-induced relaxations of the pig urinary bladder neck. Br. J. Pharmacol. 2006;149:100–109. doi: 10.1038/sj.bjp.0706832.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.bjp.0706832</ArticleId>
            <ArticleId IdType="pmc">PMC1629402</ArticleId>
            <ArticleId IdType="pubmed">16847435</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Werkström V., Alm P., Persson K., Andersson K.E. Inhibitory innervation of the guinea-pig urethra: Roles of CO, NO and VIP. J. Auton. Nerv. Syst. 1998;74:33–42. doi: 10.1016/S0165-1838(98)00135-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0165-1838(98)00135-0</ArticleId>
            <ArticleId IdType="pubmed">9858122</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hernández M., Barahona M.V., Recio P., Bustamante S., Benedito S., Rivera L., García-Sacristán A., Prieto D., Orensanz L.M. PACAP 38 is involved in the non-adrenergic non-cholinergic inhibitory neurotransmission in the pig urinary bladder neck. Neurourol. Urodyn. 2006;25:490–497. doi: 10.1002/nau.20287.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/nau.20287</ArticleId>
            <ArticleId IdType="pubmed">16721838</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jongsma Wallin H., Danielsen N., Johnston J.M., Gratto K.A., Karchewski L.A., Verge V.M.K. Exogenous NT-3 and NGF differentially modulate PACAP expression in adult sensory neurons, suggesting distinct roles in injury and inflammation. Eur. J. Neurosci. 2001;14:267–282. doi: 10.1046/j.0953-816x.2001.01641.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1046/j.0953-816x.2001.01641.x</ArticleId>
            <ArticleId IdType="pubmed">11553278</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jongsma Wallin H., Petterson L.M., Verge V.M., Danielsen N. Effect of anti-nerve growth factor treatment on pituitary adenylate cyclase activating polypeptide expression in adult sensory neurons exposed to adjuvant induced inflammation. Neuroscience. 2003;120:325–331. doi: 10.1016/S0306-4522(03)00118-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0306-4522(03)00118-0</ArticleId>
            <ArticleId IdType="pubmed">12890505</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Morton C.R., Hutchison W.D., Hendry I.A. Release of immunoreactive somatostatin in the spinal dorsal horn of the cat. Neuropeptides. 1988;12:189–197. doi: 10.1016/0143-4179(88)90054-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0143-4179(88)90054-6</ArticleId>
            <ArticleId IdType="pubmed">2907119</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sandkühler J., Fu Q.G., Helmchen C. Spinal somatostatin superfusion in vivo affects activity of cat nociceptive dorsal horn neurons: Comparison with spinal morphine. Neuroscience. 1990;34:565–576. doi: 10.1016/0306-4522(90)90165-Z.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0306-4522(90)90165-Z</ArticleId>
            <ArticleId IdType="pubmed">1972267</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Helyes Z., Than M., Oroszi G., Pinter E., Nemeth J., Keri G., Szolcsanyi J. Anti-nociceptive effect induced by somatostatin released from sensory nerve terminals and by synthetic somatostatin analogues in the rat. Neurosci. Lett. 2000;278:185–188. doi: 10.1016/S0304-3940(99)00936-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0304-3940(99)00936-2</ArticleId>
            <ArticleId IdType="pubmed">10653024</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Than M., Nemeth J., Szilvassy Z., Pinter E., Helyes Z., Szolcsanyi J. Systemic anti-inflammatory effect of somatostatin released from capsaicin-sensitive vagal and sciatic sensory fibres of the rat and guinea-pig. Eur. J. Pharmacol. 2000;399:251–258. doi: 10.1016/S0014-2999(00)00341-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0014-2999(00)00341-1</ArticleId>
            <ArticleId IdType="pubmed">10884527</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Purves-Tyson T.D., Keast J.R. Rapid actions of estradiol on cyclic amp response-element binding protein phosphorylation in dorsal root ganglion neurons. Neuroscience. 2004;129:629–637. doi: 10.1016/j.neuroscience.2004.08.019.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neuroscience.2004.08.019</ArticleId>
            <ArticleId IdType="pubmed">15541884</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Koszykowska M., Całka J., Gańko M., Jana B. Long-term estradiol-17β administration reduces population of neurons in the sympathetic chain ganglia supplying the ovary in adult gilts. Exp. Mol. Pathol. 2011;91:353–361. doi: 10.1016/j.yexmp.2011.04.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.yexmp.2011.04.002</ArticleId>
            <ArticleId IdType="pubmed">21545801</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bossowska A., Majewski M. Botulinum toxin type A-induced changes in the chemical coding of dorsal root ganglion neurons supplying the porcine urinary bladder. Pol. J. Vet. Sci. 2012;15:345–353. doi: 10.2478/v10181-012-0053-z.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2478/v10181-012-0053-z</ArticleId>
            <ArticleId IdType="pubmed">22844714</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
